Myofascial Pain Syndromes
Welcome,         Profile    Billing    Logout  
 34 Companies   37 Products   37 Products   35 Mechanisms of Action   2 Trials   396 News 


12345678»
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion:  FIBROPATHIC: Osteopathic Medicine in Fibromyalgia Syndrome (clinicaltrials.gov) -  Apr 16, 2019   
    P=N/A,  N=101, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion, Trial primary completion date:  THERMALGI: Evaluation of Spa Therapy in the Treatment of Fibromyalgia (clinicaltrials.gov) -  Jan 11, 2019   
    P=N/A,  N=220, Completed, 
    Recruiting --> Completed | Trial completion date: Feb 2017 --> Jul 2017 | Trial primary completion date: Aug 2016 --> Jul 2017 Active, not recruiting --> Completed | Trial primary completion date: Sep 2017 --> Mar 2018
  • ||||||||||  esreboxetine (AXS-14) / Axsome Therap, Pfizer
    Enrollment change:  Maintenance of Efficacy. (clinicaltrials.gov) -  Nov 29, 2018   
    P3,  N=0, Withdrawn, 
    Recruiting --> Completed N=650 --> 0
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion:  Biobehavioral Pain Management in TMD (clinicaltrials.gov) -  Jul 19, 2018   
    P=N/A,  N=300, Completed, 
    N=650 --> 0 Recruiting --> Completed
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion date, Trial primary completion date:  Radial Extracorporeal Shock Wave Treatment (rESWT) of Myofascial Pain Syndrome in Low Back Pain (clinicaltrials.gov) -  Jun 14, 2018   
    P=N/A,  N=46, Active, not recruiting, 
    Enrolling by invitation --> Completed | Phase classification: P2/3 --> PN/A Trial completion date: Jan 2015 --> Dec 2018 | Trial primary completion date: Dec 2014 --> Mar 2018
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion:  BEMER in the Treatment of Pain in Fibromyalgia. (clinicaltrials.gov) -  Jun 13, 2018   
    P=N/A,  N=110, Completed, 
    Trial completion date: Jan 2015 --> Dec 2018 | Trial primary completion date: Dec 2014 --> Mar 2018 Enrolling by invitation --> Completed
  • ||||||||||  Trial completion:  A Randomized Trial of Oral Iron Therapy in Fibromyalgia (clinicaltrials.gov) -  Apr 20, 2018   
    P3,  N=120, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  Enrollment closed, Enrollment change, Trial completion date, Trial primary completion date:  FIBROPATHIC: Osteopathic Medicine in Fibromyalgia Syndrome (clinicaltrials.gov) -  Mar 19, 2018   
    P=N/A,  N=101, Active, not recruiting, 
    Active, not recruiting --> Completed Recruiting --> Active, not recruiting | N=150 --> 101 | Trial completion date: Apr 2018 --> Aug 2018 | Trial primary completion date: Nov 2017 --> Aug 2018
  • ||||||||||  Trial completion, Trial primary completion date:  Acute Effects of Exercise in Women With Fibromyalgia (FM) (clinicaltrials.gov) -  Feb 5, 2018   
    P=N/A,  N=55, Completed, 
    Recruiting --> Active, not recruiting | N=150 --> 101 | Trial completion date: Apr 2018 --> Aug 2018 | Trial primary completion date: Nov 2017 --> Aug 2018 Recruiting --> Completed | Trial primary completion date: Dec 2017 --> Nov 2012
  • ||||||||||  Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
    Enrollment change, Trial withdrawal:  Botox for Treatment of TMJ Disorder With Bruxism (clinicaltrials.gov) -  Jan 23, 2018   
    P1,  N=0, Withdrawn, 
    Active, not recruiting --> Completed N=32 --> 0 | Not yet recruiting --> Withdrawn
  • ||||||||||  Enrollment closed, Phase classification:  THERMALGI: Evaluation of Spa Therapy in the Treatment of Fibromyalgia (clinicaltrials.gov) -  Sep 25, 2017   
    P=N/A,  N=220, Active, not recruiting, 
    Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Phase classification: P3 --> PN/A
  • ||||||||||  Trial primary completion date:  Biobehavioral Pain Management in TMD (clinicaltrials.gov) -  Aug 9, 2017   
    P=N/A,  N=300, Recruiting, 
    Recruiting --> Completed Trial primary completion date: Dec 2016 --> Apr 2018
  • ||||||||||  NN1213 / Novo Nordisk
    Phase classification:  Brief Treatment for Temporomandibular Pain (clinicaltrials.gov) -  Aug 1, 2017   
    P=N/A,  N=116, Completed, 
    Trial primary completion date: Dec 2016 --> Apr 2018 Phase classification: P1/2 --> P=N/A
  • ||||||||||  Trial completion, Trial primary completion date:  Effect of the Method Pilates in Women With Temporomandibular Disorders (clinicaltrials.gov) -  Jun 23, 2017   
    P=N/A,  N=40, Completed, 
    Recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Sep 2016 --> Jan 2017
  • ||||||||||  Trial primary completion date:  The Effect of Tai Chi in Treating Fibromyalgia (clinicaltrials.gov) -  Apr 4, 2017   
    P=N/A,  N=120, Enrolling by invitation, 
    Recruiting --> Completed | Trial primary completion date: Sep 2016 --> Jan 2017 Trial primary completion date: Dec 2016 --> Dec 2022
  • ||||||||||  Trial completion, Trial primary completion date:  The Pathogenesis of Idiopathic Dry Eyes (clinicaltrials.gov) -  Mar 15, 2017   
    P=N/A,  N=90, Completed, 
    Phase classification: P3 --> P=N/A Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Dec 2015
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Mindfulness Interventions and Chronic Widespread Pain in Adolescents (clinicaltrials.gov) -  Mar 3, 2017   
    P=N/A,  N=29, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Dec 2015 Recruiting --> Completed | N=24 --> 29 | Trial primary completion date: Dec 2017 --> Dec 2016
  • ||||||||||  fluoxetine / Generic mfg.
    Enrollment change:  Safety and Efficacy of Fluoxetine in Juvenile Fibromyalgia (clinicaltrials.gov) -  Feb 12, 2017   
    P3,  N=6, Completed, 
    Recruiting --> Completed | N=24 --> 29 | Trial primary completion date: Dec 2017 --> Dec 2016 N=15 --> 6
  • ||||||||||  triamcinolone acetonide / Generic mfg.
    Enrollment change, Trial termination:  Using Saline for Myofascial Pain Syndromes (USAMPS) (clinicaltrials.gov) -  Nov 8, 2016   
    P4,  N=51, Terminated, 
    Trial primary completion date: Nov 2016 --> Dec 2017 N=102 --> 51 | Active, not recruiting --> Terminated; lack of activity, Primary researcher moved to another institution
  • ||||||||||  Trial completion, Enrollment change:  Neurodynamic Intervention in Fibromyalgia (clinicaltrials.gov) -  Oct 28, 2016   
    P=N/A,  N=48, Completed, 
    N=102 --> 51 | Active, not recruiting --> Terminated; lack of activity, Primary researcher moved to another institution Recruiting --> Completed | N=70 --> 48
  • ||||||||||  Trial completion, Trial primary completion date:  Interdisciplinary Rehabilitation of Patients With Chronic Widespread Pain (clinicaltrials.gov) -  Aug 10, 2016   
    P=N/A,  N=192, Completed, 
    N=728 --> 907 Enrolling by invitation --> Completed | Trial primary completion date: Oct 2012 --> Jan 2014
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  ORION: Optimizing Resilience In Orofacial Pain and Nociception (clinicaltrials.gov) -  Aug 4, 2016   
    P=N/A,  N=36, Completed, 
    Enrolling by invitation --> Completed | Trial primary completion date: Oct 2012 --> Jan 2014 Recruiting --> Completed | N=50 --> 36 | Trial primary completion date: May 2016 --> Dec 2015
  • ||||||||||  Enrollment open:  FIBROPATHIC: Osteopathic Medicine in Fibromyalgia Syndrome (clinicaltrials.gov) -  Jul 6, 2016   
    P=N/A,  N=150, Recruiting, 
    Recruiting --> Completed | N=50 --> 36 | Trial primary completion date: May 2016 --> Dec 2015 Not yet recruiting --> Recruiting
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Qigong Exercise May Benefit Patients With Fibromyalgia (clinicaltrials.gov) -  Jul 5, 2016   
    P=N/A,  N=35, Completed, 
    Not yet recruiting --> Recruiting Recruiting --> Completed | N=80 --> 35 | Trial primary completion date: Jul 2012 --> Feb 2015
  • ||||||||||  Savella (milnacipran) / AbbVie, Pierre Fabre
    Phase classification:  The Effect of Milnacipran in Patients With Fibromyalgia (clinicaltrials.gov) -  Jun 30, 2016   
    P2/3,  N=37, Completed, 
    Recruiting --> Completed | N=80 --> 35 | Trial primary completion date: Jul 2012 --> Feb 2015 Phase classification: P2 --> P2/3